MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/biology11071074

Медицинская библиотека · Biology · 2022

Development of Long-Acting Human Adrenomedullin Fc-Fusion Proteins.

Nagata Sayaka, Yamasaki Motoo, Kuroishi Nobuko, Kitamura Kazuo

СтатьяПеревод пока не подготовлен

Аннотация

(1)

Background

Human adrenomedullin (hAM) is a hypotensive peptide hormone that exerts powerful anti-inflammatory effects. AM also had therapeutic effects in various animal experimental models of disease. However, treatment required continuous administration as the half-life of native AM is short in blood. To resolve this, we developed four human IgG1 and IgG4 Fc-fusion proteins containing full-length hAM or hAM residues 6-52. (2)

Methods

We used mammalian cells to produce recombinant Fc-AM derivatives and tested the pharmacokinetics and biological activity of Fc-AM. (3)

Results

We developed four Fc-fusion AMs (Fc-AM), which are long-acting AM derivatives in mammalian cells. Fc-AM had a prolonged half-life in blood and retained its ability to bind to the AM1 receptor. Fc-AM (6-52) induced higher cAMP levels for the receptor than Fc-AM. After the administration of IgG1-AM (6-52) or IgG4-AM (6-52) to rats, tissue transfer to the kidney and small intestine was observed. In addition, treatment with IgG4-AM (6-52) inhibited blood pressure increase in spontaneously hypertensive rats. (4)

Conclusions

Fc-AM produced from mammalian cells can be easily prepared and might be an effective novel therapeutic agent.

Для цитирования: Nagata Sayaka, Yamasaki Motoo, Kuroishi Nobuko, Kitamura Kazuo. Development of Long-Acting Human Adrenomedullin Fc-Fusion Proteins.. Biology. 2022. DOI: 10.3390/biology11071074.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.